Loselmeterak Tablets 20/10mg
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
MFDS item code 202007465 · Approved 2020.10.30
This product's status changed to Approval withdrawn on 2024.03.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and dyslipidemia; inhibition of atherosclerosis progression and reduction of cardiovascular disease risk
This medication is used for patients who need to receive both olmesartan medoxomil and rosuvastatin simultaneously. Olmesartan medoxomil is primarily used for the treatment of essential hypertension. Rosuvastatin helps to treat primary hypercholesterolemia and combined hyperlipidemia that cannot be managed by dietary control. It is also used as an adjunct to diet in patients with homozygous familial hypercholesterolemia and dysbetalipoproteinemia. This medication lowers blood cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis and reducing the risk of cardiovascular disease. Particularly, depending on age and risk factors, it reduces the risk of complications after stroke, myocardial infarction, and vascular revascularization procedures. Due to these effects, this medication improves cardiovascular health by managing both hypertension and dyslipidemia.
This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, olmesartan medoxomil and rosuvastatin. ◆ Olmesartan medoxomil 1. Adults The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be used in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a lower dose with careful monitoring of their condition. 2. Elderly patients No dose adjustment is required when this medicine is administered to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 30-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg once daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients. ◆ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients receiving this medicine should follow a standard cholesterol-lowering diet before and during treatment, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams once daily. 2. Elderly patients No dose adjustment is required. 3. Patients with renal impairment No dose adjustment is required for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at a dose of 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment Although systemic exposure to rosuvastatin did not increase in patients with a Child-Pugh score of 7 or less, it increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Ethnicity Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients. For patients taking olmesartan medoxomil and rosuvastatin concomitantly, they may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience.
Children under 18 years: Safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to patients with a history of allergic reactions, pregnant or potentially pregnant women, or nursing mothers. Patients with severely impaired kidney function, very poor liver function, bile duct obstruction, muscle diseases, or other specific conditions should not take this medication. Since this medication contains lactose, patients with genetic conditions such as lactose intolerance should not take it. Care is required for patients with low blood volume or insufficient sodium levels, as symptoms of hypotension may occur at the onset of taking this medication, and appropriate treatment is needed if hypotension occurs. This medication may affect kidney function, so patients with kidney disease should regularly check kidney function with blood tests. Due to the risk of hyperkalemia, blood potassium levels should be periodically monitored, and special caution is needed for patients with cardiovascular diseases. If symptoms such as myalgia or muscle weakness occur, medical personnel should be notified immediately, and the medication should be discontinued in severe cases. This medication may affect liver function, so patients with a history of liver disease should regularly have liver function tests. Dizziness or drowsiness may occur, so it is advisable to avoid dangerous machinery operation, including height work or driving. This medication may interact with other drugs, so if there are any other medications being taken, medical personnel must be informed. Pregnant or nursing women should not take this medication, and effective contraception should be used if planning to become pregnant. The safety and efficacy for children under 18 years have not been established, so use is not recommended. In the elderly, the concentration of this medication may increase, requiring dose adjustment and caution. In case of overdose, symptoms such as hypotension or arrhythmias may occur, so immediate medical assistance is required. This medication should be kept out of the reach of children, and transferring to other containers should be avoided.
Increased ALT, Increased AST, Elevated blood creatinine, Decreased creatinine clearance, Headache, Dizziness, Sensory impairment, Neuropathy, Drowsiness, Gastroesophageal reflux disease, Constipation, Dental caries, Dyspepsia, Gastric ulcer, Gastritis, Gastroenteritis, Musculoskeletal stiffness, Atrial fibrillation, Hypoglycemia, Chest pain, Tooth extraction, Chest discomfort, Peripheral edema, Vertigo, Abdominal pain, Nausea, Palpitations, Hypercholesterolemia, Hyperlipidemia, Hyperuricemia, Arthralgia, Arthritis, Myalgia, Rash, Facial edema, Asthenia, Angioedema, Anaphylaxis, Vomiting, Chronic malabsorption syndrome, Rhabdomyolysis, Hyperkalemia, Acute renal failure, Hair loss, Itching, Urticaria, Autoimmune hepatitis, Dizziness (including positional dizziness), Headache, Palpitations, Increased blood pressure, Back pain, Increased blood creatinine, Diarrhea, Cough, Epistaxis, Upper respiratory infection, Asthma, Hypersensitivity reaction including angioedema, Diabetes, Constipation, Nausea, Abdominal pain, Pancreatitis, Itching, Rash, Urticaria, Myalgia, Myopathy, Rhabdomyolysis, Asthenia, Polyneuropathy, Amnesia, Peripheral neuropathy, Dyspnea, Thrombocytopenia, Jaundice, Hepatitis, Stevens-Johnson syndrome, Drug reaction with eosinophilia and systemic symptoms, Lupus-like syndrome, Muscle rupture, Immune-mediated necrotizing myopathy, Hematuria, Edema, Depression, Sleep disorder, Interstitial lung disease, Sexual dysfunction, Gynecomastia, Fatal and non-fatal liver failure, Cognitive impairment, Severe muscle weakness, Ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius room temperature to safely maintain the medication's effectiveness.
White or yellowish round film-coated tablets
30 tablets/box [30 tablets (10 tablets/Alu-Alu) X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.